HIIFS
PPH icon

Harel Insurance Investments & Financial Services’s VanEck Pharmaceutical ETF PPH Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,350
Closed -$78K – 424
2016
Q3 		$78K Sell
1,350
-400
-23% -$24K 0.01% 184
2016
Q2 		$103K Sell
1,750
-214,040
-99% -$12.5M 0.01% 237
2016
Q1 		$12.4M Buy
+215,790
New +$12.8M 1.49% 21

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
CC
Colrain Capital Boston, Massachusetts $295M AUM 82.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Stuyvesant Capital Management Armonk, New York $41.1M AUM 17.11% 1-Year Est. Return

Harel Insurance Investments & Financial Services's PPH Position: Q4 2016 in Review

Harel Insurance Investments & Financial Services sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2016, closing a stake of 1,350 shares — an estimated $78K sold.

Harel Insurance Investments & Financial Services first reported a position in PPH in Q1 2016 and held it in 3 quarters. The position peaked at $12.4M in Q1 2016. 51 funds tracked by Wall St. Rank hold PPH as of Q4 2016.

  • Harel Insurance Investments & Financial Services reported no remaining VanEck Pharmaceutical ETF position as of Q4 2016 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 1,350 VanEck Pharmaceutical ETF shares in Q4 2016, an estimated $78K.
  • Harel Insurance Investments & Financial Services first reported a position in VanEck Pharmaceutical ETF in Q1 2016 and held it in 3 quarters.
  • Harel Insurance Investments & Financial Services's VanEck Pharmaceutical ETF position peaked at $12.4M in Q1 2016.
  • 51 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2016.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2016, filed 6 Feb 2017.